We computed descriptive statistics for the study cohort and tabulated numbers of patients using various medications and medication classes and various supplements
Important safety considerations include: Pancreatitis : Seek urgent medical attention for severe, persistent abdominal pain (which may radiate to the back), with or without vomiting Gallbladder disease : Report right upper quadrant pain, fever, or yellowing of the skin/eyes Diabetic retinopathy complications : Be aware that rapid improvement in blood glucose can temporarily worsen retinopathy
In May 2025, CVS Caremark announced that anti-obesity (AOM) tirzepatide (sold as Zepbound) would be removed from its preferred formulary effective July 1, 2025, with AOM semaglutide (sold as Wegovy) designated as the preferred alternative
According to NFPs (an Aon company) 2026 U.S
What benefits are associated with Dihexa
Post-op months 1 through 12